MapLight Therapeutics, Inc. (MPLT) at a glance

MapLight Therapeutics, Inc. (MPLT) is a Healthcare company. It trades at $27.05. It does not pay a dividend. Vestovix scores it 52/100 overall. Its strongest dimension is Momentum (65/100) and its weakest is Income (40/100).

Price
$27.06
Market cap
n/a
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$12.24 to $33.28
Vestovix Score52/ 100How this works
Value
50
Growth
50
Income
40
Safety
60
Momentum
65